UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016924
Receipt number R000019645
Scientific Title Studies on the safety and efficacy of focal transurethral resection of prostate cancer as a focal therapy for localized prostate cancer
Date of disclosure of the study information 2015/03/26
Last modified on 2021/01/31 12:26:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Studies on the safety and efficacy of focal transurethral resection of prostate cancer as a focal therapy for localized prostate cancer

Acronym

Focal transurethral resection of prostate cancer (TUR-PCa) for localized prostate cancer

Scientific Title

Studies on the safety and efficacy of focal transurethral resection of prostate cancer as a focal therapy for localized prostate cancer

Scientific Title:Acronym

Focal transurethral resection of prostate cancer (TUR-PCa) for localized prostate cancer

Region

Japan


Condition

Condition

localized prostate cancer

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

As the number of patients with low-volume, low-grade localised prostate cancer (PCa) increased, less invasive focal therapies have been introduced. We plan to study whether focal TUR-PCa could be an option among focal therapies against localized prostate cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

biochemical non-recurrence rate

Key secondary outcomes

PSA


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Focal transurethral resection of prostate cancer (TUR-PCa)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

90 years-old >=

Gender

Male

Key inclusion criteria

Patients with localized prostate cancer (T1,2N0M0)
Patients with BPH
Patients who agreed to be enrolled in the study

Key exclusion criteria

Patients who have cancer foci near bilateral nerurovascular bundle
Patients who are considered not to tolerate TURP
Patients who are considered inappropriate by the doctors

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Takeshi

Organization

Matsubara Tokushukai Hospital

Division name

Urology

Zip code

580-0032

Address

7-13-26 Amami-Higashi, Matsubara, Osaka, Japan

TEL

072-334-3400

Email

tmatsuura-jua@umin.ac.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Matsuura

Organization

Matsubara Tokushukai Hospital

Division name

Urology

Zip code

580-0032

Address

7-13-26 Amami-Higashi, Matsubara, Osaka 580-0032, Japan

TEL

072-334-3400

Homepage URL

http://www.matubara.tokushukai.or.jp/

Email

tmatsuura-jua@umin.ac.jp


Sponsor or person

Institute

Department of Urology
Matsubara Tokushukai Hospital

Institute

Department

Personal name



Funding Source

Organization

institute to carry out the study

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Kounaizaka Clinic

Name of secondary funder(s)

non


IRB Contact (For public release)

Organization

Institutional Review Boare of Matsubara Tokushukai Hospital

Address

7-13-26 Amami-Higashi, Matsubara, Osaka 580-0032, Japan

Tel

072-334-3400

Email

kiyoko.kuramitsu@tokushukai.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

松原徳洲会病院(大阪)
こうない坂医院(高知)


Other administrative information

Date of disclosure of the study information

2015 Year 03 Month 26 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://jeleu.com/index.php/JELEU/article/view/87

Number of participants that the trial has enrolled

36

Results

option as a focal therapy for localized prostate cancer.

Results date posted

2021 Year 01 Month 31 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2020 Year 06 Month 14 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 03 Month 20 Day

Date of IRB

2015 Year 03 Month 20 Day

Anticipated trial start date

2015 Year 03 Month 26 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry

2021 Year 03 Month 31 Day

Date trial data considered complete

2021 Year 06 Month 30 Day

Date analysis concluded

2021 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 03 Month 26 Day

Last modified on

2021 Year 01 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019645


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2020/12/04 Publoshed Results.docx